<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04503148</url>
  </required_header>
  <id_info>
    <org_study_id>Ane-Can Nx</org_study_id>
    <nct_id>NCT04503148</nct_id>
  </id_info>
  <brief_title>Anesthesia and Cancer Study: Renal Cell Carcinoma</brief_title>
  <official_title>The Influence of Type of Anesthesia on Recurrence of Renal Cell Carcinoma After Nephrectomy: a Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the influence of type of anesthesia on recurrence and survival of&#xD;
      renal cell carcinoma in patients undergoing nephrectomy. The participants will be allocated&#xD;
      to either the group receiving the total intravenous anesthesia (TIVA) using propofol or the&#xD;
      group receiving the inhaled anesthetics, such as sevoflurane or desflurane.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effect of anesthesia on cancer recurrence and survival is controversial. According to&#xD;
      some retrospective studies and preclinical studies, TIVA is suggested to be more favorable&#xD;
      than inhalation anesthesia regarding cancer recurrence and survival after surgery. However,&#xD;
      to our knowledge, there is no study which investigates the influence of type of anesthesia on&#xD;
      recurrence of renal cell carcinoma after nephrectomy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2020</start_date>
  <completion_date type="Anticipated">July 2025</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A prospective randomized controlled study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>one year metastasis-free survival</measure>
    <time_frame>one years after surgery</time_frame>
    <description>one year metastasis-free survival</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>three year metastasis-free survival</measure>
    <time_frame>three years after surgery</time_frame>
    <description>three year metastasis-free survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>one year survival</measure>
    <time_frame>one year after surgery</time_frame>
    <description>survival rate regardless of recurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>three year survival</measure>
    <time_frame>three year after surgery</time_frame>
    <description>survival rate regardless of recurrence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">620</enrollment>
  <condition>Renal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>TIVA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receiving the total intravenous anesthesia using propofol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>inhalation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving inhalation anesthesia using sevoflurane or desflurane</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol 1-2 mg/kg bolus injection for induction of anesthesia propofol continuous infusion for maintenance of anesthesia</description>
    <arm_group_label>TIVA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inhaled General Anesthetics</intervention_name>
    <description>Sevoflurane or desflurane for induction and maintenance of anesthesia</description>
    <arm_group_label>inhalation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients scheduled for elective nephrectomy due to renal cell carcinoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency surgery&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Allergies to anesthetics&#xD;
&#xD;
          -  Palliative surgery&#xD;
&#xD;
          -  Refusal to participate in the study&#xD;
&#xD;
          -  History of diagnosis or surgery for other cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jin-Tae Kim</last_name>
    <phone>821062608490</phone>
    <email>jintae73@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin-Tae Kim, Pf.</last_name>
      <phone>+82-2-2072-3295</phone>
      <email>jintae73@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>August 3, 2020</study_first_submitted>
  <study_first_submitted_qc>August 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2020</study_first_posted>
  <last_update_submitted>October 22, 2020</last_update_submitted>
  <last_update_submitted_qc>October 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Propofol</keyword>
  <keyword>Inhaled anesthetics</keyword>
  <keyword>Renal cell carcinoma</keyword>
  <keyword>Nephrectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Anesthetics, General</mesh_term>
    <mesh_term>Anesthetics, Inhalation</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

